Published in Anal Biochem on June 15, 2007
Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets. Acta Pharmacol Sin (2009) 0.86
Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell (2005) 2.74
Fluorouracil: biochemistry and pharmacology. J Clin Oncol (1988) 2.46
Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem (1991) 2.19
The feedback inhibition of thymidine kinase. Biochim Biophys Acta (1963) 2.10
Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A (1996) 1.87
Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci U S A (2002) 1.81
Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia (2002) 1.36
Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin Cancer Res (2005) 1.19
Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Ther (1999) 1.17
Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci (2002) 1.15
Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem (1999) 1.13
A rapid assay for nucleotide kinases using C14-or H3-labeled nucleotides. Anal Biochem (1963) 1.12
First principles calculations of the pKa values and tautomers of isoguanine and xanthine. Chem Res Toxicol (2003) 0.93
A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing. Gene Ther (2006) 0.93
Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. Cancer Cell (2002) 0.92
Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants. Gene Ther (2006) 0.91
Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities. Biochemistry (2000) 0.91
Imaging herpes viral thymidine kinase-1 reporter gene expression with a new 18F-labeled probe: 2'-fluoro-2'-deoxy-5-[18F]fluoroethyl-1-beta-d-arabinofuranosyl uracil. Nucl Med Biol (2005) 0.87
Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins (2000) 0.87
Genital herpes: antiviral therapy for symptom relief and prevention of transmission. Expert Opin Pharmacother (2006) 0.86
Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation. J Biol Chem (2006) 0.85
Folding and self-assembly of herpes simplex virus type 1 thymidine kinase. J Mol Biol (2001) 0.85
Interaction of calf-thymus DNA with trivalent La, Eu, and Tb ions. Metal ion binding, DNA condensation and structural features. J Biomol Struct Dyn (1993) 0.85
The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase. Biochemistry (2002) 0.83
Quantitation of pulmonary transgene expression with PET imaging. J Nucl Med (2004) 0.82
A simple radioisotopic assay for nucleoside kinases employing alumina for separation of nucleosides and nucleotides. Anal Biochem (1981) 0.81
Imaging pulmonary gene expression with positron emission tomography. Am J Respir Crit Care Med (2002) 0.81
Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK. Nucleosides Nucleotides Nucleic Acids (2006) 0.81
Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: Initial experience at Kobe University. Int J Urol (2006) 0.79
A new method for quantitative determination of tritium-labeled nucleoside kinase products adsorbed on DEAE-cellulose. Biochem Biophys Res Commun (1996) 0.79
Detection of thymidine kinase activity using an assay based on the precipitation of nucleoside monophosphates with lanthanum chloride. Anal Biochem (1989) 0.79
An efficient washing procedures for thymidine kinase assay. Neurochem Res (1981) 0.77
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron (2000) 22.02
The acute respiratory distress syndrome. N Engl J Med (1995) 5.24
Characterization of a component of the yeast secretion machinery: identification of the SEC18 gene product. Mol Cell Biol (1988) 3.74
Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis (1992) 3.64
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Relation of breast cancer with passive and active exposure to tobacco smoke. Am J Epidemiol (1996) 2.93
A population-based study of the usefulness of screening for neuroblastoma. Lancet (1997) 2.92
Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg (1986) 2.72
Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg (1998) 2.17
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood (1994) 2.14
Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest (1991) 2.03
Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci U S A (1999) 2.02
Characterization of a gene product (Sec53p) required for protein assembly in the yeast endoplasmic reticulum. J Cell Biol (1985) 1.97
Significance of hemorrhage into brain tumors: clinicopathological study. J Neurosurg (1987) 1.95
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med (1984) 1.76
Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum (1997) 1.75
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys (1998) 1.72
Multidrug resistance transporters and modulation. Curr Opin Oncol (2000) 1.71
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene (2006) 1.70
Absence of p53 gene mutations in primary neuroblastomas. Cancer Res (1993) 1.69
Spinal cord concussion. J Neurosurg (1990) 1.68
Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med (1994) 1.67
Product of SEC53 is required for folding and glycosylation of secretory proteins in the lumen of the yeast endoplasmic reticulum. J Biol Chem (1987) 1.67
International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res (2009) 1.56
Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med (1990) 1.52
A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis (1987) 1.52
Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil (2014) 1.48
The changing clinical presentation of complete molar pregnancy. Obstet Gynecol (1995) 1.47
Modified stereotactic insertion of the Ommaya reservoir. Technical note. J Neurosurg (2000) 1.46
Na/H exchange in cultured chick heart cells. pHi regulation. J Gen Physiol (1985) 1.44
Treatment efficacy is not an index of pain intensity. Can J Anaesth (2000) 1.43
Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res (1990) 1.43
Management decisions in children with nephroblastomatosis. Med Pediatr Oncol (2000) 1.42
C1-C2 posterior cervical fusion: long-term evaluation of results and efficacy. Neurosurgery (1995) 1.42
Pituitary apoplexy associated with a triple bolus test. Case report. J Neurosurg (1984) 1.41
Ventilator-associated pneumonia: clinical considerations. AJR Am J Roentgenol (1994) 1.41
Isolated right ventricular myocardial infarction. Ann Intern Med (1993) 1.40
Tuberculous mastitis. South Med J (1994) 1.40
Awake craniotomy with brain mapping as the routine surgical approach to treating patients with supratentorial intraaxial tumors: a prospective trial of 200 cases. J Neurosurg (1999) 1.39
The genie in the bottle. Ann Intern Med (1998) 1.38
Emergency lumbar puncture in adults. Can Fam Physician (1989) 1.38
Intracellular water-specific MR of microbead-adherent cells: the HeLa cell intracellular water exchange lifetime. NMR Biomed (2008) 1.35
Acute subdural hematoma from ruptured posterior communicating artery aneurysm. Neurosurgery (1988) 1.35
Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med (1992) 1.34
Multilevel anterior cervical corpectomy and fibular allograft fusion for cervical myelopathy. J Neurosurg (1997) 1.34
Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med (1983) 1.33
Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study. J Pediatr Hematol Oncol (1998) 1.32
Molecular imaging in vivo with PET and SPECT. Acad Radiol (2001) 1.30
The value of reoperation for recurrent glioblastoma. Can J Surg (1993) 1.26
Community-based surveillance of cardiovascular risk factors in Geneva: methods, resulting distributions, and comparisons with other populations. Prev Med (1997) 1.24
Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug Chem (2000) 1.24
Access to intensive care unit beds for neurosurgery patients: a qualitative case study. J Neurol Neurosurg Psychiatry (2003) 1.23
Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry (2000) 1.22
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Decreased anion gap associated with monoclonal and pseudomonoclonal gammopathy. Can Med Assoc J (1976) 1.21
Phase I therapy trials in children with cancer. J Pediatr Hematol Oncol (1998) 1.19
Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med (1984) 1.18
Thalamic tumors in children. Long-term follow-up and treatment guidelines. J Neurosurg (1984) 1.17
Detection and enumeration of antibody-producing cells by specific adherence of antigen-coated bentonite particles. J Immunol (1966) 1.17
Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg (2001) 1.16
Physicians' response to abnormal results of routine urinalysis. Can Med Assoc J (1976) 1.16
Conduct of phase I trials in children with cancer. J Clin Oncol (1998) 1.16
Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med (1987) 1.15
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Res (2001) 1.15
A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther (1999) 1.12
Isolated vasculitis of the central nervous system in a patient with celiac disease. Am J Med (1986) 1.11
Interstitial irradiation of brain tumors: a review. Neurosurgery (1981) 1.11
Isolated oculomotor nerve palsy: an unusual presentation of glioblastoma multiforme. Case report and review of the literature. J Neurooncol (1999) 1.10
The liver lesion in Q fever. Clinical and pathologic features. Arch Intern Med (1965) 1.10
Complications of first craniotomy for intra-axial brain tumour. Can J Neurol Sci (1994) 1.09
Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am J Respir Crit Care Med (1999) 1.08
A phase I study of irinotecan in pediatric patients: a pediatric oncology group study. Clin Cancer Res (2001) 1.08
Microsurgical resection of solitary intramedullary spinal cord metastases. Neurosurgery (1987) 1.08
Body weight preoccupation in middle-age and ageing women: a general population survey. Int J Eat Disord (1998) 1.07
Moraxella ovis in cases of infectious bovine keratoconjunctivitis (IBK) in Israel. Zentralbl Veterinarmed B (1988) 1.07
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. Leukemia (2012) 1.07
Intracellular pH regulation in cultured embryonic chick heart cells. Na(+)-dependent Cl-/HCO3- exchange. J Gen Physiol (1990) 1.06
Modulation of the multidrug resistance P-glycoprotein: detection with technetium-99m-sestamibi in vivo. J Nucl Med (1997) 1.06
Methicillin nephritis. Medicine (Baltimore) (1977) 1.05
Clinical styles and motivation: a study of laboratory test use. Med Care (1975) 1.05
Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation. Oncogene (2010) 1.05
Laparoscopic colorectal surgery: analysis of 140 cases. Surg Endosc (1996) 1.05
Laparoscopic vs open colon surgery. Costs and outcome. Surg Endosc (1995) 1.04
Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Biochemistry (1997) 1.04
Cerebral hyperperfusion after carotid endarterectomy: a cause of cerebral hemorrhage. Neurosurgery (1984) 1.04
Re: "Smoking and breast cancer: reconciling the epidemiologic evidence by accounting for passive smoking and/or genetic susceptibility". Am J Epidemiol (1998) 1.03
Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin. Biochem Pharmacol (2000) 1.02
Early metabolic improvement following bariatric surgery in morbidly obese adolescents. Pediatr Blood Cancer (2011) 1.01
Phase I trials in pediatric oncology: perceptions of pediatricians from the United Kingdom Children's Cancer Study Group and the Pediatric Oncology Group. J Clin Oncol (2000) 1.00
Theoretical effects of transmembrane electroneutral exchange on membrane potential. J Gen Physiol (1984) 0.99
Intracellular water specific MR of microbead-adherent cells: HeLa cell intracellular water diffusion. Magn Reson Med (2008) 0.99
Microfluorometric monitoring of pHi in cultured heart cells: Na+-H+ exchange. Am J Physiol (1983) 0.98
Multidrug resistance (MDR1) P-glycoprotein enhances esterification of plasma membrane cholesterol. J Biol Chem (1999) 0.98
Rosai-Dorfman disease mimicking multiple meningioma: case report. Neurosurgery (1995) 0.98
Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med (1998) 0.97
Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant (2004) 0.97
Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care (1997) 0.97
Transmembrane chloride flux in tissue-cultured chick heart cells. J Gen Physiol (1983) 0.97